Female Viagra and Female Sexual Disorder Treatment

Female Sexual Disorder (FSD) is common among women, with 30 to 40 percent of women in the US and Europe reporting problems with lack of sexual interest, lack of pleasurable sex, and difficulty reaching orgasm. Common problems that decrease a woman’s sexual desire include physical problems and emotional problems including; family concerns, relationship fear, previous or existing emotional or physical abuse, fatigue, and depression.

FSD is classified as a disorder associated with decrease in sexual desire, arousal, orgasm, and painful intercourse. It is the recurring inability to achieve or maintain enough lubrication and genital swelling to complete sexual activity. Many women who are taking antidepressants experience these sexual problems. Although once thought to be a psychological problem, doctors are now focusing on physical reasons for lack of desire for sexual intercourse and researching possible treatments.

Female Viagra is a phosphodiesterase type-5 (PDE5) inhibitor, and has been successful in treating erectile disfunction in males, although few studies have been conducted in the treatment of female sexual disorders. However, PDE5 was found to be involved in the smooth muscle tissue of the vagina, clitoris, and labia, and it plays an important role in female genital arousal. The presence of PDE5 is much lower in female sexual organs than in the male penis.

Women that are taking sildenafil for FSD report increased vaginal vascular engorgement, improved clitoral responsiveness, and greater vaginal lubrication. The results of studies are inconclusive, but have shown that about 20 percent of women having difficulties with vaginal lubrication responded positively to sildenafil treatment, with increased blood flow to the vagina and clitoris causing greater female arousal.

In placebo-controlled studies, women suffering from Female Sexual Arousal Disorder (FSAD) experienced significant benefits from taking sildenafil. These women suffered from physical problems associated with sexual arousal such as lack of blood flow to the genitals and lack of natural lubrication. Those women suffering from Hypoactive Sexual Desire Disorder (HSDD) had minimal effects from taking sildenafil. These problems are characterized by a lack of desire for sexual activity, and are likely to be caused by underlying emotional and psychological problems.

Sildenafil Feminine is an oral medication that is effective 45 minutes after it is taken, and remains in effect for up to six hours. This drug increases vaginal blood flow and enhances the pleasure of sexual intercourse. It improves the sensitivity of the vaginal region and naturally increases lubrication.